Webinar Date/Time: Thu, Dec 12, 2024 11:00 AM EST
Sterile filtration is a crucial step within multiple market segments—eg, bioprocessing, medical, etc—where performance, safety, and quality are all critical. Discover how to optimize and properly size sterile filtration process steps for a wide range of different applications.
Register Free: https://www.biopharminternational.com/bp_w/sterile-filtration
Event Overview:
Within this webinar, the focus will be on understanding how to size a sterilizing grade filtration process step through filterability methodologies. We will discuss the value of a pre-filter and how this can impact the sterilizing grade filter performance. The filterability methodologies evaluated will include Pmax and Vmax. Sterile filtration is a critical step within multiple market segments e.g., Bioprocessing, Medical, etc, where product performance and quality are critically important. In sterile filtration, at a retention level of 0.2 micron, allows for the removal of microorganism and/or contaminants from product fluid streams and provides sterile effluents for further processing. Optimizing a filtration step is critical to ensure process, cost, and scaling efficiencies are maximized for optimal filtration performance. Moreover, filter sizing has an impact on single use design considerations with filtration integration, in PUSIT for example, are critical and need to be considered for efficient processing.
As Entegris is a leading filtration manufacturer, we will discuss the value proposition of sizing sterile filtration solutions and how it integrates into single use systems while maximizing performance.
Key Learning Objectives:
Who Should Attend:
Speaker:
Chris Rios
Sr. Field Applications Engineer
Entegris
Chris Rios has 10+ of experience working in Life sciences with a focus in single use components and sterile filtration. He has held multiple technical roles supporting end-users in bioprocessing and medical device development and co-developed engineering solutions. Before joining Entegris, Chris worked at Millipore Sigma and Saint-Gobain. He received his Bachelor of Science in Bioengineering and Economics and is a Master of Science in Bioengineering from George Mason University.
Register Free: https://www.biopharminternational.com/bp_w/sterile-filtration
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.